Jiangsu gdk Biotechnology Co Ltd Class A 688670
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 13.29
- Day Range
- CNY 12.76–13.29
- 52-Week Range
- CNY 12.76–50.80
- Bid/Ask
- CNY 12.78 / CNY 12.81
- Market Cap
- CNY 1.57 Bil
- Volume/Avg
- 729,945 / 656,919
Key Statistics
- Price/Earnings (Normalized)
- 17.79
- Price/Sales
- 41.43
- Dividend Yield (Trailing)
- 1.50%
- Dividend Yield (Forward)
- —
- Total Yield
- 1.50%
Company Profile
Jiangsu gdk Biotechnology Co Ltd is a biological high-tech enterprise integrating scientific research, production, operation and service of human vaccines. The company's product pipeline covers prevention of five important infectious diseases such as influenza, rabies, chickenpox, shingles and pneumonia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 451
- Website
- http://www.gdkbio.com
Comparables
Valuation
|
Metric
|
688670
|
300841
|
02179
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.79 | 12.57 | — |
Price/Book Value | 1.21 | 2.09 | 4.89 |
Price/Sales | 41.43 | 4.64 | — |
Price/Cash Flow | 56.47 | 11.40 | — |
Price/Earnings
688670
300841
02179
Financial Strength
|
Metric
|
688670
|
300841
|
02179
|
|---|---|---|---|
Quick Ratio | 1.40 | 4.14 | 3.86 |
Current Ratio | 3.34 | 4.49 | 3.99 |
Interest Coverage | −80.32 | 119.95 | −84.89 |
Quick Ratio
688670
300841
02179
Profitability
|
Metric
|
688670
|
300841
|
02179
|
|---|---|---|---|
Return on Assets (Normalized) | −4.87% | 15.03% | −23.96% |
Return on Equity (Normalized) | −5.91% | 17.64% | −46.33% |
Return on Invested Capital (Normalized) | −5.65% | 16.65% | −30.73% |
Return on Assets
688670
300841
02179
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Jqqlvbkd | Rvp | $635.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Sdvcpmvx | Fksctr | $124.1 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Pscdcjrbs | Rhpysm | $114.2 Bil | |||
| Moderna Inc
MRNA
| Byrzgbhx | Wwljb | $53.7 Bil | |||
| argenx SE ADR
ARGX
| Qdkctdyfw | Dcj | $23.0 Bil | |||
| BioNTech SE ADR
BNTX
| Cqbndvhb | Rmhrp | $22.2 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Ynyybpsb | Vgxybkw | $20.3 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Zhvqclyhq | Zlfnphf | $15.9 Bil | |||
| United Therapeutics Corp
UTHR
| Sfgvsfll | Qvlj | $12.8 Bil | |||
| Incyte Corp
INCY
| Yfxfnrntq | Kythjpt | $12.2 Bil |